Investigating whether serum IGF-1 and IGFBP-3 levels reflect the height outcome in prepubertal children upon rhGH therapy: LG growth study database.
Serum insulin-like growth factor-1 (IGF-I) and IGF binding protein-3 (IGFBP-3) levels can be used to monitor the safety of recombinant human growth hormone (rhGH) therapy. In this study, we evaluated the changes in serum IGF-I and IGFBP-3 levels during rhGH therapy as a marker of height outcome in p...
Saved in:
Main Authors: | Minsun Kim, Eun Young Kim, Cheol Hwan So, Chan Jong Kim |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/b4d10d32c3da4c6fbaeb6b7014dc8bfe |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Investigating whether serum IGF-1 and IGFBP-3 levels reflect the height outcome in prepubertal children upon rhGH therapy: LG growth study database
by: Minsun Kim, et al.
Published: (2021) -
Decreased Thyroxine Levels during rhGH Therapy in Children with Growth Hormone Deficiency
by: Ewelina Witkowska-Sędek, et al.
Published: (2021) -
Analysis of the Influence of High-Dose rhGH Therapy on Serum Vitamin D and IGF-1 Levels in School-Age Children with Idiopathic Short Stature
by: Juan Li, et al.
Published: (2021) -
Factors affecting IGF-I level and correlation with growth response during growth hormone treatment in LG Growth Study.
by: Ji Hyun Kim, et al.
Published: (2021) -
Expression of genes encoding IGF1, IGF2, and IGFBPs in blood of obese adolescents with insulin resistance
by: Minchenko Dmytro O., et al.
Published: (2019)